As previously announced, the Board still believes that this assessment is without merit and maintains its position based on the legal advice received and independent reviews of the Group's systems. The Company continues to take all appropriate legal channels to challenge the assessment received.
Back to All News
All Market News
Other Market News
Capital Gearing Trust – Final Results
JP Morgan China Growth & Income – Half Year Report
SSE – Preliminary Results
Scottish Mortgage – Final Results
B.P. Marsh – Final Results
FDA Decision Date on AstraZeneca’s Camizestrant Extended
Sign up for our Stock News Highlights
Delivered to your inbox every Friday